Inferensys

Glossary

Somatic Variant Classification

The computational task of distinguishing acquired mutations present only in tumor cells from inherited germline polymorphisms and sequencing artifacts using a matched tumor-normal sample pair.
Product manager reviewing autonomous task execution dashboard on laptop, completed tasks visible, casual work session.
PRECISION ONCOLOGY

What is Somatic Variant Classification?

The computational task of distinguishing acquired mutations present only in tumor cells from inherited germline polymorphisms and sequencing artifacts using a matched tumor-normal sample pair.

Somatic variant classification is the algorithmic process of labeling genetic alterations identified in a tumor sample as somatic mutations, germline variants, or sequencing artifacts. It operates on a matched tumor-normal pair to subtract the patient's inherited genetic background, isolating mutations acquired during oncogenesis. The core challenge lies in modeling variant allele fractions (VAF) and read-level error profiles to differentiate low-frequency true mutations from technical noise.

Modern classifiers integrate deep learning with Bayesian statistical frameworks, analyzing features like strand bias, base quality, and local sequence context. By assigning probabilistic scores to each variant, these systems enable clinical labs to prioritize driver mutations for targeted therapy while filtering out benign polymorphisms and homopolymer indel errors that plague next-generation sequencing data.

SOMATIC VARIANT CLASSIFICATION

Core Discriminative Features

The computational logic that separates true tumor-specific mutations from inherited polymorphisms and technical noise using a matched tumor-normal pair.

01

Tumor-Normal Subtraction Logic

The foundational principle of somatic calling relies on a matched tumor-normal pair from the same individual. By comparing the Variant Allele Fraction (VAF) and genotype likelihoods at every locus, the algorithm subtracts the germline baseline. A variant present in the tumor but absent in the normal sample is classified as a somatic mutation. This direct subtraction eliminates the need for population-level frequency databases to filter private germline variants, though it requires precise read-backed phasing to avoid misclassifying low-purity tumor signals as heterozygous germline events.

99.9%
Germline subtraction specificity
02

Variant Allele Fraction (VAF) Modeling

Somatic classification hinges on the Variant Allele Fraction—the ratio of reads supporting the alternate allele to total depth. Unlike the fixed 50% or 100% ratios expected in germline heterozygosity or homozygosity, somatic VAFs are continuous and influenced by tumor purity and clonal heterogeneity. Advanced callers build statistical models of expected VAF distributions to distinguish true subclonal mutations from strand bias artifacts or homopolymer indel errors. A low VAF in the normal sample often indicates a sequencing error or circulating tumor DNA contamination rather than a true germline event.

< 5%
Detectable subclonal VAF
03

Artifact Source Discrimination

The primary challenge is rejecting false positives that mimic somatic mutations. Key discriminative features include:

  • Strand Bias: Variant alleles concentrated on a single DNA strand indicate oxidative damage during library preparation.
  • Mapping Quality: Low mapping quality scores at the locus suggest mismapped reads or paralogous sequences.
  • Base Quality Dropoff: Systematic reduction in base quality scores near the variant position flags sequencing cycle errors.
  • Homopolymer Length: Indels in repetitive contexts are weighted against known polymerase slippage error rates. Classifiers integrate these features to assign a somatic probability score.
04

Joint Genotyping vs. Single-Sample Calling

While single-sample somatic callers operate on one tumor-normal pair, joint genotyping across a cohort of tumors can rescue low-VAF mutations missed in individual samples. By sharing statistical evidence across multiple samples, the model learns locus-specific error profiles and identifies recurrent hotspot mutations. However, this approach risks cross-sample contamination and requires strict batch effect correction. Modern deep learning callers like DeepVariant treat each sample independently but leverage population-informed priors during training to improve rare variant sensitivity.

05

Local Reassembly for Complex Events

Simple alignment-based subtraction fails at loci with complex somatic events like multi-nucleotide variants (MNVs) or small insertions adjacent to deletions. Local reassembly performs targeted de novo assembly of reads mapping to a candidate region, constructing a De Bruijn graph to resolve the true haplotypes. This approach distinguishes a single complex somatic event from two adjacent simple germline variants, preventing incorrect classification. The reassembled contigs are realigned to the reference to generate a precise CIGAR string describing the somatic edit.

06

Somatic-Germline-Zygosity Classification

Modern classifiers output a three-way probability distribution: somatic, germline, or loss of heterozygosity (LOH). LOH events occur when the tumor loses one parental allele, converting a heterozygous germline site to an apparently homozygous somatic state. Distinguishing LOH from a true somatic mutation requires analyzing the B-allele frequency across a haplotype block and integrating copy number variation calls. This multi-class framework prevents the misclassification of copy-neutral LOH as a somatic point mutation.

SOMATIC VARIANT CLASSIFICATION

Frequently Asked Questions

Answers to the most common technical questions about distinguishing true tumor-specific mutations from inherited polymorphisms and sequencing artifacts using matched tumor-normal analysis.

Somatic variant classification is the computational process of distinguishing acquired mutations present only in tumor cells from inherited germline polymorphisms and technical sequencing artifacts. The process requires a matched tumor-normal pairing strategy, where both cancerous tissue and healthy tissue from the same individual are sequenced simultaneously. The classifier operates by comparing Variant Allele Fraction (VAF) ratios between the two samples—a true somatic mutation will show a significantly higher VAF in the tumor sample relative to the matched normal, while germline variants maintain consistent allele fractions across both tissues. Modern deep learning classifiers, such as DeepVariant adapted for somatic calling, encode aligned reads into pileup images and apply convolutional neural networks to learn complex features including strand bias patterns, mapping quality distributions, and base quality profiles that distinguish true biology from systematic errors like homopolymer indel errors and strand bias artifacts.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.